PTC Inc. stock is a Buy as Creo & Windchill drive R&D lock-in, 27% RPO growth, and 95% recurring revenue, plus $365M buybacks. Click here to read more on PTC.

PTC unveiled the next generation of its computer-aided design (CAD) application suite Thursday and executives said the new product would provide the company's system integration and ISV partners with ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

PTC has just launched a new suite of apps called creo, which it says will support its vision for MCAD for the next 20 years. Each app is intended to supply the appropriate, role-specific tool, to a ...

SOUTH PLAINFIELD, N.J., April 14, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today introduced a new no-charge, patient-initiated testing program in the United States for individuals ...